What are Generics?
Generic drugs marketed without brand names contain the exact same active ingredients used in their brand-name counterparts, but cost significantly less. The drugs are required to meet U.S. Food and Drug Administration (FDA) standards for safety, purity and effectiveness.
Generic Hydrea (Hydroxyurea) is often used to treat cases of chronic ovarian cancer, myelocytic leukemia, melanoma and squamous cell cancer in the head and neck. Generic Hydrea may also be used to mollify certain forms of sickle cell anemia and other blood cell illnesses. One of the most trusted names in cancer treatments, Generic Hydrea works to stop the growth and spreading of sickly cancer cells and damaged red blood cells.
Generic Hydrea may also be marketed as: Hydroxyurea, Hydrea, Droxia.
*Hydrea® is manufactured by Bristol-Myers Squibb Company